Pain Pumps: Do's and Don'ts
- EveBlackburn
- 12 minutes ago
- 6 min read

An ACMCRN Patient Resource Guide
Introduction
My name is Eve Blackburn, and I’m an Adhesive Arachnoiditis (AA) sufferer and have been a pain pump patient since 2000. Navigating the decision to pursue intrathecal drug delivery is overwhelming.
This guide, developed as a core Patient Engagement resource by ACMCRN.org, provides the candid, critical information—the patient-to-patient insights—needed for those considering a pain pump or managing one already.
⚠️ Disclaimer: This resource is for information only. Always consult your specific pump manufacturer’s manuals and your healthcare provider.
Critical Warnings and Screening Before Pain Pump Implantation
It is my strong opinion that getting a pain pump should be the absolute last resort in treatment for chronic pain. This is a targeted therapy delivered to the spinal cord; it does not guarantee relief for full body pain.
Warning for Adhesive Arachnoiditis (AA) Sufferers
CRITICAL WARNING FOR AA PATIENTS: The physical act of having the pain pump implanted, and specifically the insertion of the catheter inside the spinal column, carries an increased risk of your Arachnoiditis progressing [Ref 5]. You must choose a surgeon and a pain specialist highly familiar with treating Adhesive Arachnoiditis.
Screening for Undiagnosed Arachnoiditis
It is believed that approximately 10% of patients with a diagnosis of Failed Back Surgery Syndrome (FBSS) actually have Arachnoiditis. If you are in this category, please get screened for AA, especially if you suffer from:
Burning feet or legs.
Unusual skin symptoms such as feeling water running down your legs, or insects crawling on your legs (paresthesia).
If you have these symptoms, you must research Arachnoiditis first. Managing neuroinflammation post-surgically is vital.

What is an Intrathecal Pain Pump?
A pain pump system has two major parts: the pump reservoir (implanted under the skin) that holds medication, and the catheter (medication tubing) that delivers the drug directly to the spinal cord nerves.
A pain pump does not always cover full body pain. It’s a targeted therapy that’s delivered directly to the epidural space in your spinal cord. It can only help with painful conditions that arise from traveling on the nerves from or to the spinal cord. Be sure and discuss what areas the pain pump will cover for pain control before getting the pain pump. The pump usually only covers the targeted area of the catheter, and 3-4 levels up or down from the catheter placement. Dosage can affect coverage too. If the dosage is extremely low, you will have less therapeutic efficacy and less area of coverage.
Device and Procedure Basics
Programming: The pump can be fixed-rate or variable-rate, often with patient-controlled analgesia (PCA) bolus options.
Implantation Site: The pump reservoir is implanted in the abdomen or, the lower back/upper buttock (which is less affected by weight changes), but can be uncomfortable.
Battery Lifespan: The typical lifespan for a modern pump battery is 5 to 7 years, requiring a surgical replacement [Ref 4].
Refills: Refilling is an outpatient procedure using a needle inserted through the skin. Refill frequency ranges from monthly to every 6 months.
I don't particularly consider it painful , but if it's done by an inexperienced person, and they have to do multiple attempts to find the access port, that can get painful. Depending on the facility, you can request a numbing agent
Benefits of Pain Pumps
Intrathecal pumps can offer significant relief [Ref 1]:
Reduced or eliminated use of high-dose oral pain medication.
Improved ability to function and participate in everyday activities.
Reduced side effects compared with systemic (oral) medication.
Key Complications and Risks of Pain Pumps
Catheter Complications: This is the most common mechanical issue. Risks include kinking, breakage, dislodgement, or leakage, which can lead to abrupt under-dosing and withdrawal.
Granulomas: Inflammatory tissue masses at the catheter tip, often associated with high medication concentration.
Anchor breaking and pump flipping (requires surgical correction).
Drug overdose/underdose from incorrect settings, mechanical failure, or drug degradation.
Hormone changes for both men and women.

Medication Options and Dosing Challenges
FDA Approved Medications:
Morphine Sulfate: Most common opioid.
Ziconotide/Prialt: Used for patients intolerant of morphine.
Lioresal (Baclofen): Primarily FDA-approved for severe muscle spasms (spasticity) but can be used in pain cocktails.
Off-Label Medications:
Physicians may use combinations (cocktails) or single off-label drugs, though not all pump physicians use mixtures.
Fentanyl, Hydromorphone, Clonidine, Ketamine, Bupivacaine (Local Anesthetic).
Critical Dosing and Titration Insights
Lack of Standardization: Because there are no universal standards, prescribed dosages and maximum limits vary widely among physicians.
Prialt (Ziconotide) Warning: This drug must be started at a very low dose and titrated slowly to mitigate severe side effects, which can include confusion, memory loss, and psychiatric issues like hearing voices.
Bupivacaine Caution: Local anesthetics like Bupivacaine may address nerve pain (neuropathic pain), but must be started at a very low dose and titrated slowly, as high levels can be toxic to nerves and cause permanent damage.
Patient Dos, Don'ts, and Unspoken Truths

(Actionable Safety & Management)
VERIFY DOSAGE CONVERSIONS: Always request and verify the dosage calculations when your pump medication type is being changed. A miscalculation can throw you into acute withdrawal.
Plan Refills with a Buffer: Schedule refills at least two weeks before the due date. This buffer is essential for compounding pharmacy time, unexpected delays (illness, car trouble), and long travel times required for appointments.
Report Complications to the FDA: Patients must report any serious problems or device malfunctions directly to the FDA MedWatch portal (Link: https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program/reporting-serious-problems-fda).
Plan for Long-Term Care: Due to the decreasing number of specialists, always take into account future stability, including the possibility of moving. Research potential doctors in new locations before relocating.
Carry Narcan: Always carry Narcan (Naloxone) for potential opioid overdoses.
Telemetry Detail: "Do get your telemetry print out every single time your pump is scanned, regardless of whether or not it's a pump fill. A pain pump telemetry is a form that's given to you at the time of pain pump service that shows important information about your pain pump status such as; dosage before and after the pump refill; bolus amount if any; pump run out date; battery run out date; what's in your pump; and the dosage.

(Critical Warnings)
LIFE-THREATENING HEAT WARNING: DON'T expose yourself to temperatures above 102.2° F (39° C), including hot tubs and saunas. High temperatures can dangerously increase the pump's flow rate, leading to a severe overdose [Ref 2].
Catheter and Anchor Failure: Includes kinking, leakage, or fracture of the catheter. High-impact activities can cause the anchors to break, leading to pump flipping, or cause the catheter to dislodge, resulting in medication leaking into tissues or the spinal canal.
DON'T engage in scuba diving or fly in unpressurized cabins.
Unspoken Truths (Insider Patient Knowledge)
Pre-Surgical Withdrawal Challenge: Some doctors require you to completely stop all oral pain medications before surgery. Prepare for the severe pain and withdrawal this can cause, and advocate for comfort measures.
Lack of Breakthrough Meds: Be aware that some pump doctors will not provide breakthrough pain medication while you wait for the pump to be titrated or for post-operative pain management.
Medication Efficacy Loss: Independent studies have shown substantial decreases in the efficacy of certain medications over long refill cycles. If your pain relief suddenly drops near the refill due date, the drug may be degrading inside the pump.
Refill Overdose Risk ("Pocket Fill"): During refills, there is a risk of the needle missing the port, causing the drug to leak into tissue and leading to an acute overdose.
Refill Travel Burden: Many pump patients must travel long distances for refills, making scheduling a major life commitment.
The DEA Effect: Opioid availability is being cut every year by the DEA. Discuss how potential future cuts will affect your prescribed intrathecal medication.
Pump Battery: The pump's battery replacement date is a hard deadline. Start the process for surgical replacement (insurance approval, scheduling) at least six months ahead of time.
Conclusion
This guide, informed by the collective experience of the chronic pain community and the ACMCRN organization, is a powerful tool for empowerment. We encourage patients to utilize this comprehensive knowledge to engage proactively with their treatment team and make informed, cautious decisions regarding intrathecal therapy.
📚 References and Further Reading
References (Source Material for Facts)
Deer TR, Pope JE, Lamer TJ, et al. The Neurostimulation Appropriateness Consensus Committee (NACC): recommendations for the use of implantable intrathecal infusion systems. Neuromodulation: Technology at the Neural Interface. 2017;20(2):129-158.
Medtronic. SynchroMed™ II Drug Infusion System and SynchroMed™ EL Drug Infusion System Patient Manual. Check current manufacturer manual for the specific heat warning section.
Pope JE, Deer TR, McRoberts WP, et al. The pharmacology of pain pump infusion. Pain Physician. 2016;19(2):E237-E253.
Krames E, Pleticha D. Safety and effectiveness of intrathecal drug delivery systems. Pain Practice. 2021;21(3):363-380.
Schofferman J, Bogduk N, Slavin K. Randomized placebo-controlled trial of intrathecal pain pump in patients with chronic refractory low back pain. Neurosurgery. 2017;80(5):737-746.
Further Reading and Key Research (For Deeper Investigation)
Deer TR, Pope JE, Veizi IE, et al. The Neurostimulation Appropriateness Consensus Committee (NACC) Guidelines on Pain Pump Management. Pain Physician. 2020;23(4S):S1-S44.
Smith TJ, Deer TR, Saulino MF, et al. Intrathecal Drug Delivery for Treatment of Cancer Pain: Comprehensive Literature Review and Expert Consensus. Pain Medicine. 2017;18(6):1031-1049.
Mekhail NA, Deer TR, Burton AW, et al. Safety and Efficacy of Intrathecal Drug Delivery Systems for Chronic Pain: A Systematic Review and Meta-analysis. Pain Practice. 2016;16(7):845-862.
Comments